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ABSTRACT. There are only a few studies done on pulmonary effects of passive smoking from India,
which are summarized in this paper.  Several vernacular tobacco products are used in India, bidis (beed-
is) being the commonest form of these. Bidis contain a higher concentration of nicotine and other tobac-
co alkaloids compared to the standard cigarettes (e.g., the sum of total nicotine and minor tobacco alka-
loids was 37.5 mg in bidi compared to 14-16 mg in Indian or American cigarettes in one study). A large
study performed on 9090 adolescent school children demonstrated environmental tobacco smoke (ETS)
exposure to be associated with an increased risk of asthma. The odds ratio for being asthmatic in ETS-
exposed as compared to ETS-unexposed children was 1.78 (95% CI: 1.33-2.31). Nearly one third of the
children in this study reported non-specific respiratory symptoms and the ETS exposure was found to be
positively associated with the prevalence of each symptom. Passive smoking was also shown to increase
morbidity and to worsen the control of asthma among adults. Another study demonstrated exposure to
ETS was a significant trigger for acute exacerbation of asthma. Increased bronchial hyper-responsiveness
was also demonstrated among the healthy nonsmoking adult women exposed to ETS. Passive smoking
leads to subtle changes in airflow mechanics. In a study among 50 healthy nonsmoking women passively
exposed to tobacco smoke and matched for age with 50 unexposed women, forced expiratory volume in
first second (FEV1) and peak expiratory flow (PEF) were marginally lower among the passive smokers
(mean difference 0.13 L and 0.20 L-1, respectively), but maximal mid expiratory flow (FEF25-75%), air-
way resistance (Raw) and specific conductance (sGaw) were significantly impaired. An association
between passive smoking and lung cancer has also been described. In a study conducted in association with
the International Agency for Research on Cancer, the exposure to ETS during childhood was strongly
associated with an enhanced incidence of lung cancer (OR = 3.9, 95% CI 1.9-8.2). In conclusions several
adverse pulmonary effects of passive smoking, similar to those described from the western and developed
countries, have been described from India.
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INTRODUCTION
Passive smoking or environmental tobacco smoke (ETS) expo-
sure has been variously described as ‘second-hand smoke’ or
‘involuntary smoking’. In the past, little attention, beyond its
nuisance effect, was paid to the health consequences of passive
smoking.  Exhaustive report on health consequences of invol-
untary smoking by the United States Surgeon General [1] and
reports by the United States Environmental Protection
Agency [2] highlighted the increased risks of several diseases
similar to those seen among smokers, in persons exposed to
ETS at home or at work place. Several hundred studies were
quoted in these reports, which cited various pulmonary and
extra-pulmonary health effects of passive smoking. But most
of these studies were reported from the Western and devel-
oped countries.  There are very few reports on the health
effects of passive smoking from the developing and the under-
developed countries.  
Smoking is on the rise in developing countries although
there are differences in tobacco products, quality of tobacco
used and the smoking practices [3]. Environmental conditions
such as the overcrowding and the poor ventilation at homes
and work places may make the health effects of ETS more pro-
nounced. There are a few studies on pulmonary effects of pas-
sive smoking from India. In this paper, we review the pub-
lished information available from India on pulmonary effects
of passive smoking.
COMPOSITION OF ETS
Tobacco smoke contains over 4000 chemicals in the forms of
particles and gases [2]. ETS is a combination of sidestream
(SS) smoke emitted from the burning end of a cigarette and
the remainder of mainstream (MS) smoke exhaled by a smok-
er. The sidestream smoke constitutes about 85% of the smoke
present in the room where active smokers smoke, and contains
many potentially toxic components, some of which may occur
in even higher concentrations than in the mainstream smoke
[4]. The particulate phase consists of tar (itself composed of
many chemicals), nicotine, benzo(a)pyrene, and hundreds of
other noxious compounds. A few examples of gases in tobacco
smoke are carbon monoxide, benzene, ammonia, dimethylni-
trosamine, formaldehyde, hydrogen cyanide and acrolein.
Some of these constituents have marked irritant properties
and there are found to be about 60 known or suspected human
carcinogens present in tobacco smoke. The environmental
tobacco smoke has been classified as class A (known for
human) carcinogen along with asbestos, arsenic, benzene and
radon gas [5].
The most popular Indian smoking product is “bidi” (also
spelled as beedi). Bidis are made of crude sun-dried tobacco
wrapped in a dried Tendu (Dyospyros melanoxylon) leaf.
Another smoking product used in different parts of India is
“chillum” or “hooka”, which resembles a pipe made of clay.
Tobacco is burnt along with molasses and coal, and smoked
either directly or through a long pipe with smoke passing
through a water container. The amount of nicotine and tobac-
co alkaloids present in the mainstream smoke (MS) of these
vernacular tobacco products is likely to be different from those
present in the MS of standard cigarettes because of the differ-
ences in their design (e.g. water acts as a filter in hooka and no
filter exists in most bidis). The sidestream (SS) smoke released
from such products is also likely to be different from the SS of
standard cigarettes due to differences in tobacco processing,
burning rate and temperature, and the use of additives for
burning tobacco. In a study from Mumbai, the bidi, an Indian
cigarette and a brand of American cigarette were analyzed by
gas chromatography-flame ionization detection for the levels
of nicotine and minor tobacco alkaloids in the MS and SS
smoke [6]. The analysis demonstrated higher total nicotine
and minor tobacco alkaloids in tobacco from bidi (37.7 mg/g)
compared to Indian or American cigarettes (14-16 mg/g). This
study also demonstrated higher delivery of nicotine and alka-
loids by bidi as evidenced by higher concentration of nicotine
in the MS smoke (MS/SS) compared to that released by a reg-
ular cigarette. In another study from Mumbai, air samples
from different indoor environments were analyzed for the lev-
els of various volatile organic compounds. A very high level of
benzene was detected in a smoker’s room and in a kitchen
using kerosene as fuel [7].
QUANTIFYING PASSIVE SMOKING
One of the very difficult tasks in most studies on passive smok-
ing is to quantify an ETS exposure. Most epidemiological stud-
ies of ETS depend largely on the validity of self-reported expo-
sure. In a large multi-country collaborative study, which
included Chandigarh as one of the collaborating centers, the
self-reported ETS exposure among nonsmoking women mar-
ried to smokers at home or at work was evaluated. This study
was conducted in 13 centers across 10 countries and included
1,369 nonsmoking married women. Urinary cotinine levels
were measured and correlated with the history of ETS expo-
sure. It was demonstrated that nonsmoking women could pro-
vide appropriate estimates of their exposure, which well corre-
lated with their biochemically measured exposure levels. The
results of a linear regression analysis indicated that the dura-
tion of exposure and the number of cigarettes to which the
subjects reported to be exposed were strongly correlated with
the levels of  urinary cotinine excretion. The number of ciga-Pulmonary effects of passive smoking 131
rettes was the best measure of exposure to husbands’ smoking,
while exposure at workplace was more strongly related to the
duration of exposure [8]. It was also shown that the potential
bias due to smoker misclassification was very unlikely to be
responsible for the increased health risks observed in the epi-
demiological studies on ETS [9].
PASSIVE SMOKING AND LUNG
FUNCTIONS
There is a biological plausibility that passive smoking can
affect the pulmonary functions similar to the effects of active
smoking. There are only a few cross-sectional and longitudinal
studies that have shown ETS exposure as an important risk
factor for obstructive lung disease with a significant dose
response relationship [10,11]. Controlled acute exposure to
ETS also results in some decrements in lung volumes and
flows [12].
In a study from Chandigarh on 200 school children, the
effects of passive smoking and domestic cooking fuels on lung
function were evaluated. It was observed that spirometric
indices were lower in children exposed to biomass fuels vis-a-
vis liquid petroleum gas at home. All the indices studied such
as vital capacity (VC), forced expiratory volume in first second
(FEV1), FEV1/VC ratio, peak expiratory flow (PEF) and max-
imal mid expiratory flow (FEF25-75%) were also lower among
passive smokers, though statistically significant difference was
observed only in mid expiratory flows among children exposed
to mixed fuels [13].
Recently, we have also studied airflow mechanics in
asymptomatic healthy women to evaluate the effects of long-
term exposure to ETS (unpublished data). Lung functions
[including VC, FEV1, FEV1/VC ratio, PEF, FEF25-75%, air-
way resistance (Raw) and specific conductance (sGaw)] were
compared among 50 healthy nonsmoking women exposed to
passive smoking (Group I) and age matched 50 women not
similarly exposed (Group II). Conditional and logistic linear
regression analyses were performed to assess contribution of
household ETS-exposure to decreased lung function after
adjusting for potential confounders.  The results have
demonstrated that although FEV1 and PEF of passive smok-
ers were only marginally lower than the controls (mean dif-
ference 0.13 L and 0.20 L-1 respectively), their FEF25-75%,
Raw and  sGaw were significantly impaired. Ten (20%)
women exposed to ETS and five (10%) unexposed had
abnormal Raw (adjusted odds ratio 6.72, 95% confidence
interval 1.15-39.42), while eight (16.0%) women in group I
and only 1 (2%) in group II had abnormal sGaw (adjusted
odds ratio 21.08, 95% CI = 1.30-341.05). 
Bronchial hyper responsiveness (BHR) is  an important
determinant of decline in lung function in normal subjects and
those with chronic bronchitis [14]. Parental smoking has shown
to be associated with BHR in children [15]. We have studied
BHR, as measured by methacholine broncho-provocation test,
in three groups of nonsmoking housewives with or without his-
tory of exposure to ETS or biomass fuel combustion [16]. The
first group comprised of 60 controls, all being nonsmokers
with no history of chronic exposure to   environmental tobac-
co smoke (ETS) or biomass fuels. Three of these women
showed a 20 per cent FEV1 fall with a cumulative metha-
choline dose of 72.5 mg or less. Of 60 women in group II (ETS-
exposed) and 52 in group III (biomass fuel exposed), 26
(43.3%) and 10 (19.2%) showed bronchial BHR, respectively.
The odds ratios for BHR in groups II and III were 14.53 and
4.52, respectively, compared to controls. The number of hyper-
responders was significantly more and the mean PD20 was less
among the exposed than among the unexposed group. The
occurrence of BHR was more evident among the ETS-exposed
group (P < 0.05) than among the biomass-combustion group.
There were more hyper-responders among group II and those
who had an overall higher cumulative exposure as measured
by an exposure index of 50 or more [exposure index (EI) is
equal to an average daily number of cigarettes or bidis to
which exposure is reported, multiplied by the number of years
during which such an exposure occurred], compared to those
with EI of less than 50. An ETS-exposure may thus either
unmask the inherent BHR or sensitize hitherto non-reactive
airways.
Passive smoking can cause subtle changes in lung function.
Several earlier studies have also shown similar findings. The
magnitude of reported changes, however, has been small both
in cross-sectional and longitudinal studies. Some investigators
have reported a significant decrease in FEV1 [17,18], while
some others have documented non-significant lower values
[19,20]. A significant decrement in the mid-expiratory flow
rates observed in our studies on both children and adult
women, points towards narrowing of the small airways in a
fashion similar to the known observations among active smok-
ers [21]. However, larger longitudinal trials are needed to eval-
uate progression of this impairment with continued exposure
to ETS.
PASSIVE SMOKING AND ASTHMA
The noxious effects of passive smoking on asthma are fre-
quently described and debated. Passive smoking has been
linked to the causation, increased morbidity and acute exacer-
bation of asthma [22].
The role of ETS in causing asthma has now been world-
wide accepted. The International Consultation on
Environmental Tobacco Smoke (ETS) and Child Health held
in Geneva, Switzerland, concluded that ETS exposure causes a132 Gupta D et al.
wide variety of adverse health effects in children, including
lower respiratory tract infections such as pneumonia and bron-
chitis, coughing and wheezing, initiation and worsening of
asthma, and middle ear disease [23]. Cross sectional studies
have consistently revealed a detrimental effect of parental
smoking, especially maternal, on lung function and/or severity
of asthma in children [24]. There are increases in both preva-
lence and severity of asthma in children exposed to ETS from
parental smoking. We have conducted a large community
based survey for prevalence of asthma among adolescent
school children in Chandigarh [25]. Using a previously stan-
dardized questionnaire [26], data from 9090 students in the 9
to 20 year age range were analyzed. There were 4367 (48%)
boys, among whom the observed prevalence of asthma was
2.6%. Among 4723 (52%) girls, asthma was present in 90
(1.9%) students. A greater number of asthmatic students had
either smoking parents or other family members who smoked
at home as compared to non-asthmatics (41% vs. 28%, p <
0.0001). The odds ratio for being asthmatic for patients
exposed to ETS compared to unexposed patients was 1.78
(95% confidence interval 1.33-2.31). Another study from the
neighbouring state of Haryana, involved 2000 school children
in rural settings using the International Study of Asthma and
Allergy in Children (ISAAC) questionnaire [27]. Among
these, forty children were found to be asthmatic. Each asth-
matic child was matched with two healthy kids of the same age
and sex from the same study population. An in-depth interview
on possible risk factors was done for each case and its controls.
The results of the multivariable analyses have shown that pas-
sive smoking was an important risk factor associated with asth-
ma (OR 3.33, 95% CI = 1.85-7.65), besides the other factors
such as having pets at home and the absence of windows in liv-
ing rooms [28]. However, a smaller hospital based study in
children from Delhi, failed to show any significant risk of
developing asthma with passive smoking [29]. Conceptually,
children, whose respiratory and immune systems are in the
developing state, are more vulnerable than adults to ETS
exposure [30]. Children also spend more time at home and get
exposed to smoking from parents. In a meta-analysis, the
pooled odd’s ratio for asthma prevalence from 14 case control
studies was 1.37 (95% CI 1.15-1.64) [31]. The International
Consultation report referring to this latter has also concluded
that both asthma and respiratory symptoms (wheeze, cough,
breathlessness and phlegm) are indeed increased among chil-
dren whose parents smoke; the results of over 60 studies on
school-aged children have shown that the pooled relative risks
for either parent smoking range from 1.2 to 1.4 [23].
ETS has adverse effects on asthmatic adults too. Various
observational studies have reported worsening or precipita-
tion of respiratory and nasal symptoms, cough and wheeze on
exposure to ETS in allergic individuals [32]. One of the earli-
est studies documenting adverse effects of passive smoking
on asthma in adults was conducted at our center [33]. The
study was undertaken to compare the indices of morbidity
and control of asthma in 100 adult patients exposed to ETS
(group 2), with 100 asthmatics not exposed (group 1).
Exposure was established from the history of smoking by the
patient's spouse and other close contacts. Indices of asthma
control and morbidity included the emergency department
(ED) visits, hospitalization, acute episodes, requirement of
parenteral drugs at home, corticosteroids, and maintenance
bronchodilators in the preceding 1-year period. An index per
patient was also calculated. Lung function was recorded by
the measurement of forced expiratory flows on the same day
of the follow-up visit. The mean age and disease duration
were comparable, but the expiratory flows were lower in the
patients exposed to ETS. More patients in this group had
required daily bronchodilators (66 percent) and intermittent
corticosteroids (56 percent) than patients from the other
group. The number of ED visits, acute episodes, and par-
enteral bronchodilators per patient were significantly more
(p < 0.01) in group 2 patients. Similarly, the number of weeks
of absence from work and of corticosteroids requirement
were more (p < 0.01) among the ETS-exposed patients
(Table 1). Subsequently, we had studied the role of ETS
exposure in causing acute exacerbations of asthma [34]. One
hundred patients of asthma seen in the emergency room with
an acute attack of less than 24 hour duration were inter-
viewed for exposure to known asthma triggers including ETS
in the preceding 24 hours and were compared with 100 stable
patients of asthma. Sixty-seven patients with acute exacerba-
tion could point to a possible triggering factor. There was a
significantly higher prevalence of exposure to ETS in patients
with acute exacerbations compared to stable asthmatics (41%
vs.  20%; p<0.01). ETS was the only significant identifiable
trigger for acute asthma in 33 ETS-exposed patients.
Bronchial hyper-responsiveness is central to pathophysiol-
ogy of asthma. We have also studied the effect of chronic ETS
exposure on bronchial responsiveness by measuring BHR in
stable, nonsmoking asthmatic women and compared the PD20
in ETS exposed and unexposed patients [35]. Histamine bron-
cho provocation test was performed on 50 patients with stable
asthma, of whom 23 (46%) were exposed to ETS (mean expo-
sure 1.22 + 0.61 hours/day for 13.07 + 6.1 years). The PD20
was significantly lower in the ETS-exposed than in unexposed
group (mean 5.66 + 9.62 vs. 11.8 + 13.06 units, median 1.7 vs.
6.1 units). The morbidity indices in the ETS group were also
worse than in the control group. It is, therefore, likely that con-
tinued and chronic ETS exposure, especially when heavy,
worsens asthma control by exacerbation of BHR. The adverse
effects of ETS on asthma are corroborated by several inhala-
tion challenge studies [36,37].  Pulmonary effects of passive smoking 133
PASSIVE SMOKING AND
RESPIRATORY SYMPTOMS
IN CHILDREN
Passive smoking increases the risk of lower respiratory tract infec-
tions such as bronchitis, pneumonia and bronchiolitis in children.
The International Consultation report [23] concluded that
parental smoking is an important cause of lower respiratory tract
illnesses (e.g. croup, bronchitis, bronchiolitis, and pneumonia)
during the first years of life. Of over 40 studies, all but one, have
reported an increased risk among children whose parents smoke.
Pooling the studies’ results, children whose mothers smoke are
estimated to have a 1.7-fold (95% CI = 1.6-1.9) higher risk of
these illnesses than children of nonsmoking mothers. Paternal
smoking alone causes a 1.3-fold (95% CI = 1.2-1.4) increase in
risk. This result shows a strong evidence for a causal role of ETS
exposure, since it is uncomplicated by maternal smoking during
pregnancy. Similar effects were also seen for both wheezing and
non-wheezing illnesses, and across studies done in communities
and hospitals. In an asthma prevalence study we mentioned
before [25], 31% of students reported the presence of one or more
respiratory symptoms. ETS was also positively associated with
prevalence of all respiratory symptoms, with odds ratios varying
between 1.6 and 2.25 (Table 2). Similarly, a study was carried out
to find out the prevalence and common causes of chronic/recur-
rent cough among rural children in Ludhiana (Punjab), India [38].
The prevalence of cough was 1.06% among a study sample of 2275
children. Asthma was the commonest cause of this cough (66.7%)
followed by post-nasal drip (25%). Significantly, the family histo-
ry of smoking was present in 16.7% of children with cough com-
pared to 6.4% of children without cough. 
Group 1 
(n = 100)
Group 2 
(n = 100)
Emergency department visits 0.6 0.82*
Hospitalization 0.33 0.34
Acute episodes 0.6 1.32*
Parenteral bronchodilators (no.) 6.0 8.6*
Absence from work (weeks) 3.0 3.6*
Steroid requirement (weeks) 8.6 11.3*
Bronchodilators requirement (weeks) 36.3 38.3
Table 1. Indices of asthma control (per patient in the preceding 1 year) in ETS exposed and
unexposed asthmatic patients
* p < 0.01; Group 1 = Not exposed to ETS; Group 2= Exposed to ETS (Reproduced with
permission from reference 33).
Exposed
(n = 2574)
Unexposed
(n = 6516)
Crude O.R. 
(95% C.I.) *
Age and sex adjustedO.R.
(95% C.I.) *
Asthma (questionnaire diagnosis) 84 (3.3%) 121 (1.9%) 1.783 (1.345-2.364) 1.780 (1.340-2.364)
Symptoms
Wheeze 226 (8.8%) 364 (5.6%) 1.627 (1.369-1.933) 1.605 (1.349-1.910)
Chest tightness 220 (8.5%) 345 (5.3%) 1.671 (1.402-1.992) 1.690 (1.417-2.017)
Dyspnea on exertion 425 (16.5%) 676 (10.4%) 1.708 (1.499-1.948) 1.689 (1.481-1.927)
Dyspnea at rest 129 (5.0%) 207 (3.2%) 1.608 (1.284-2.013) 1.671 (1.333-2.095)
Dyspnea at night 134 (5.2%) 205 (3.1%) 1.690 (1.353-2.112) 1.702 (1.360-2.129)
Cough at night 355 (13.8%) 556 (8.5%) 1.715 (1.488-1.976) 1.754 (1.521-2.023)
Cough in morning 210 (8.2%) 308 (4.7%) 1.790 (1.493-2.047) 1.763 (1.469-2.117)
Phlegm in morning 384 (14.9%) 586 (9.0%) 1.773 (1.545-2.035) 1.761 (1.533-2.023)
Phlegm for >3 months 152 (6.7%) 224 (4.0%) 1.698 (1.374-2.099) 1.719 (1.388-2.129)
Chest tightness on exposure to allergens 425 (16.5%) 526 (8.1%) 2.252 (1.964-2.583) 2.245 (1.956-2.577)
Dyspnea on exposure to allergens 432 (16.8%) 658 (10.1%) 1.796 (1.575-2.047) 1.881 (1.648-2.147)
Table 2. Prevalence of respiratory symptoms and asthma with reference to ETS exposure at home
* Odds ratio and 95% confidence interval (Reproduced with permission from reference 25).134 Gupta D et al.
PASSIVE SMOKING AND LUNG
CANCER
Nonsmoking individuals with long-term ETS-exposure have an
increased risk of lung cancer. Hackshaw et al. reviewed 37 epi-
demiological studies on the risk of lung cancer in nonsmoking
persons (4626 cases) [39]. It was found that lifetime risk of
lung cancer in nonsmoking persons who lived with a smoker
was 24% (95% CI 13% to 20%). Tobacco specific carcinogens
have also been detected in the blood of the ETS exposed non-
smoking persons providing clear evidence of the ETS associa-
tion. A dose-response relationship between the nonsmoker’s
risk of lung cancer and cumulative exposure to ETS was also
demonstrated in this review [39]. More recently, Taylor and
colleagues  have done a cumulative meta-analysis incorporat-
ing 43 studies (meeting their inclusion criteria from a total 76
primary epidemiological studies and 20 meta-analyses report-
ed between 1981 and 1999) [40]. The pooled relative risk (RR)
for never-smoking women exposed to ETS from spouses, com-
pared with unexposed never-smoking women was 1.29 (95%
CI 1.17-1.43).
In our experience, active smoking remains the strongest
risk factor for developing lung cancer particularly among
men. The association of lung cancer with smoking seems to
be weaker in women as compared to men; an observation
based on a study that only about one third of our female
patients with lung cancer were smokers compared to nearly
90% of men with such malignancies [41]. In a recent study by
us, we have interviewed 265 histologically confirmed lung
cancer patients (235 men, 30 women) and 525 hospital con-
trols (435 men, 90 women) matched for age and sex, by a pre-
designed questionnaire. The effects of individual variables
defining various aspects of tobacco smoking, indoor and out-
door air pollution and occupational exposure were assessed
using unconditional logistic regression models. Eighty nine
per cent of men and 33 per cent of women among the
patients were ever-smokers as compared to 60 per cent of
men and 20 per cent of women among the controls. The Odds
Ratio (OR) for ever-smoking was 5.0 (CI 3.11-8.04) among
men and 2.47 (CI 0.79-7.75) among women [42]. We have
looked into the role of passive smoking in 58 histologically
proven cases of nonsmokers’ lung cancer using a case-control
study with two age-and-sex matched controls per each patient
[43]. Subjects were asked about their ETS exposure from dif-
ferent tobacco products beginning from childhood onwards
at home, at workplace and in vehicles. Multivariable logistic
analysis was done to assess the effects of ETS exposure on
lung cancer. Exposure to ETS during the childhood was
strongly associated with lung cancer (OR = 3.9, 95% CI 1.9-
8.2) (Fig. 1). Restricting the analysis to women produced
higher estimates of the risk (OR = 12, 95% CI 4.3-32). The
observed risk was higher for ETS exposure through cigarettes
as compared to bidis or chilum; a finding that is consistent
with the observation of comparative composition of MS and
SS smoke from different tobacco products as mentioned
before [6]. A weaker association was seen between lung can-
cer and ETS exposure from spouse, at workplace and in vehi-
cles. Another interesting observation was made in the earlier
collaborative study of the International Agency for Research
on Cancer (IARC) in Chandigarh as one of the study centers
[44]. Some of the excess risk of lung cancer development in
nonsmoking women from spousal smoking was attributable
to the childhood ETS-exposure from parental smoking. It
was also shown that indeed daughters of smoking parents
more often tended to marry smokers (71% of women with
smoking husbands had one or both parents smoking com-
pared to 60.3% of women married to nonsmokers, who had
at least one smoking parent; OR for the daughter of a smok-
er to marry a smoker was 1.64, 95% CI = 1.24-2.17), thus
compounding the effects of parental and spousal ETS expo-
sure. Therefore, ETS exposure, which is a recognized risk
factor in countries with high prevalence of smoking, is also a
risk factor in India, which historically has a low prevalence of
smoking and lung cancer [45].
To summarize, passive smoking has several subtle as well
as overt pulmonary effects.  It is an established risk factor for
lung cancer in nonsmoking persons. It is a significant risk fac-
tor for the respiratory symptoms and asthma in children. It is
associated with an increased morbidity from asthma in
adults, which is difficult to control. Passive smoking can also
lead to a poor lung function, small airway dysfunction, and
increased bronchial hyper-responsiveness in asymptomatic
nonsmokers.
Fig. 1. A chest roentgenogram (PA view) of a non-smoking housewife
with prolonged history of ETS exposure from father and spouse show-
ing a mass lesion in right mid-zone, which turned out to be bron-
chogenic squamous cell carcinoma.Pulmonary effects of passive smoking 135
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